ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DAB Dexion Abs

171.75
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dexion Abs LSE:DAB London Ordinary Share GB0032287020 £ SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 171.75 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dexion Absolute Ltd Estimated NAV 11.03.2016

18/03/2016 2:32pm

UK Regulatory


 
TIDMDAB TIDMDABE TIDMDABU 
 
Dexion Absolute Limited (the "Company") 
 
Estimated Net Asset Value 
 
Ordinary Shares 
 
As at the close of business on 11 March 2016, the estimated net asset value of 
the Company's ordinary shares is as follows:- 
 
Ordinary        NAV per Share     Performance   MTD Performance* YTD Performance 
Share Class                        since 04 
                                     March 
 
GBP Shares        182.53 pence        +0.15%           +0.01%           -3.65% 
 
*Based on the Estimate NAV for 29 February 2016 reported on 04 March 2016. 
 
This valuation, which has been prepared in good faith by the Company's 
administrator, is for information purposes only and is based on the unaudited 
estimated valuations supplied to the Company's investment adviser by the 
administrators or managers of the Company's underlying investments and such 
valuations may not be considered independent or may be subject to potential 
conflicts of interest. Both weekly manager estimates and monthly valuations may 
be produced as at valuation dates which do not co-incide with valuation dates 
for the Company, may be based on valuations provided as of a significantly 
earlier date, may differ materially from the actual value of the Company's 
portfolio and are unaudited or may be subject to little verification or other 
due diligence and may not comply with generally accepted accounting practices 
or other generally accepted valuation principles. The Company's investment 
adviser, investment manager and administrator may not have sufficient 
information to confirm or review the completeness or accuracy of information 
provided by those managers or administrators of the Company's investments. In 
addition, those entities may not provide estimates of the value of the 
underlying funds in which the Company invests on a regular or timely basis or 
at all with the result that the values of such investments may be estimated by 
the investment adviser. Since 1 April 2013 the Company has been transitioning 
to becoming a feeder fund of Aurora Offshore Fund Ltd II ("AOFL II"). AOFL II's 
investment manager is also the investment adviser to the Company and so 
valuations of the Company's investment in AOFL II may be subject to potential 
conflicts of interest. As at 1 March 2016 approximately 105.42% of the 
Continuing Portfolio (by NAV) was invested in AOFL II. The value of designated 
investments as at 1 March 2016 equates to approximately 1.08% of the Continuing 
Portfolio NAV. Certain other risk factors which may be relevant to these 
valuations are set out in the Company's prospectus dated 17 October 2007 and 
the Company's circulars dated 15 April 2011, 5 April 2012, 22 February 2013, 27 
May 2013 and 26 August 2015. 
 
 
 
END 
 

(END) Dow Jones Newswires

March 18, 2016 10:32 ET (14:32 GMT)

1 Year Dexion Absolute Chart

1 Year Dexion Absolute Chart

1 Month Dexion Absolute Chart

1 Month Dexion Absolute Chart

Your Recent History

Delayed Upgrade Clock